Qiagen

Yahoo Finance • 7 days ago

QIAGEN to advance AI-driven drug discovery with graph-based AI and curated bioinformatics knowledge with NVIDIA

Collaboration integrates NVIDIA accelerated computing and the NVIDIA BioNeMo platform with QIAGEN Digital Insights’ curated biomedical knowledge bases Goal to advance how disease mechanisms, therapeutic targets and biomarkers are identifie... Full story

Yahoo Finance • 12 days ago

QGEN SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Qiagen N.V. (“Qiagen” or the “Company”) (NYSE:QGEN) investors concerning the Company’s and/or members of i... Full story

Yahoo Finance • 14 days ago

Nucleic Acid Isolation and Purification Market Report 2026-2030: Trends, Challenges and Competitive Analysis Featuring Thermo Fisher Scientific, Merck, QIAGEN, and Roche

Company Logo Nucleic Acid Isolation and Purification MarketNucleic Acid Isolation and Purification Market·GlobeNewswire Inc. Dublin, May 12, 2026 (GLOBE NEWSWIRE) -- The "Nucleic Acid Isolation and Purification Market by Product, Method,... Full story

Yahoo Finance • 17 days ago

Water Utility Up Just 8% in a Year Faces $28 Million Position Cut

On May 8, 2026, Nuance Investments disclosed in an SEC filing that it sold 515,078 shares of H2O America in the first quarter, an estimated $28.04 million trade based on the quarterly average price. What happened Nuance Investments reduc... Full story

Yahoo Finance • 23 days ago

Is IDEAYA Biosciences, Inc. (IDYA) A Good Stock To Buy Now?

Is IDYA a good stock to buy? We came across a bullish thesis on IDEAYA Biosciences, Inc. on Valueinvestorsclub.com by pestopenguin. In this article, we will summarize the bulls’ thesis on IDYA. IDEAYA Biosciences, Inc.'s share was trading... Full story

Yahoo Finance • 28 days ago

Qiagen N.V. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

SAN DIEGO, April 28, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Qiagen N.V. (NYSE: QGEN). The investigation focuses on Qiagen’s executive officers and whether investor losses... Full story

Yahoo Finance • 28 days ago

AI Fears and Surging Crude Oil Prices Weigh on Stocks

The S&P 500 Index ($SPX) (SPY) today is down -0.66%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.03%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -1.30%.  June E-mini S&P futures (ESM26) are down -0.63%, and June E-mini Nasd... Full story

Yahoo Finance • last month

Tesla upgraded, AppLovin initiated: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: UBS upgraded Tesla (TSLA) to Neutral f... Full story

Yahoo Finance • last month

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Biogen, Birkenstock, Fastly, Ford, Lennox International, Netskope, SanDisk, Tesla, and More

Quick Read Despite the shares falling, Goldman Sachs kicked off the first-quarter earnings season with terrific results. Even though the Iran peace talks ended without a resolution, the potential for initial dialogue is solid, which helpe... Full story

Yahoo Finance • 2 months ago

Bruker Announces Appointment of Thierry Bernard to its Board of Directors

Thierry Bernard BILLERICA, Mass., April 01, 2026--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) announces the appointment of Mr. Thierry L. Bernard to serve on its Board of Directors, effective as of today. Mr. Bernard is an internat... Full story

Yahoo Finance • 2 months ago

Liquid Biopsy Products Market Report 2026-2031 Featuring Analysis of Roche, Illumina, Qiagen, MDxHealth, Novogen, BGI, Myriad Genetics and More

Company Logo Dublin, March 20, 2026 (GLOBE NEWSWIRE) -- The "Liquid Biopsy Product Market Report: Trends, Forecast and Competitive Analysis to 2031" has been added to ResearchAndMarkets.com's offering. The global liquid biopsy product m... Full story

Yahoo Finance • 3 months ago

Qiagen CEO says working with advisers on strategic review

[Qiagen Markets QIAstat-Dx For Coronavirus Testing] Sascha Schuermann/Getty Images News Qiagen NV (QGEN [https://seekingalpha.com/symbol/QGEN]) CEO Thierry Bernard said the company is working with Moelis & Co. and Goldman Sachs to review... Full story

Yahoo Finance • 3 months ago

Immunoassay for Neurological Biomarkers Market Research 2026 - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030

Company Logo The market for immunoassays targeting neurological biomarkers is driven by the global rise in neurological disorders, increasing demand for early diagnostics, AI integration enhancing biomarker detection, and personalized the... Full story

Yahoo Finance • 3 months ago

Personalized Medicine Market Competitive Landscape Report 2025: Company Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033

Company Logo Personalized Medicine Market Poised for Tremendous Growth by 2033The global personalized medicine market, valued at approximately US$ 585.53 billion in 2026, is projected to soar to nearly US$ 1.00 trillion by 2033. A report... Full story

Yahoo Finance • 3 months ago

Cancer Diagnostics Market Competitive Landscape Report 2025: Key Players Analysis, Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033

Dublin, Feb. 24, 2026 (GLOBE NEWSWIRE) -- The "Cancer Diagnostics Market Key Players Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts" report has been added to Rese... Full story

Yahoo Finance • 4 months ago

Qiagen targets 9% growth in 2026 growth pillars and $2B by 2028 with new product launches

Earnings Call Insights: Qiagen N.V. (QGEN) Q4 2025 MANAGEMENT VIEW * Thierry Bernard, CEO, stated that "QIAGEN continued to perform and delivered a solid finish to '25 with results in the fourth quarter, again above outlook." Bernard h... Full story

Yahoo Finance • 4 months ago

Qiagen Non-GAAP EPS of $0.62 in-line, revenue of $540M beats by $11.51M

* Qiagen press release [https://seekingalpha.com/pr/20388557-qiagen-exceeds-q4-2025-outlook-driven-by-growth-pillars] (QGEN [https://seekingalpha.com/symbol/QGEN]): Q4 Non-GAAP EPS of $0.62 in-line. * Revenue of $540M (+3.6% Y/Y) beats... Full story

Yahoo Finance • 6 months ago

Oracle Names Stephen Rusckowski to the Board of Directors

AUSTIN, Texas, Nov. 20, 2025 /PRNewswire/ -- Oracle Corporation (NYSE: ORCL) today announced that it unanimously elected Stephen Rusckowski to Oracle's Board of Directors and increased the size of the Board to 14. The election is effective... Full story

Yahoo Finance • 7 months ago

Qiagen NV Q3 25 Earnings Conference Call At 9:30 AM ET

(RTTNews) - Qiagen NV (QGENF) will host a conference call at 9:30 AM ET on November 5, 2025, to discuss Q3 25 earnings results. To access the live webcast, log on to https://event.webcasts.com/starthere.jsp?ei=1709559&tp_key=263df2a108 T... Full story

Yahoo Finance • 7 months ago

QGEN Crosses Below Key Moving Average Level

In trading on Tuesday, shares of Qiagen NV (Symbol: QGEN) crossed below their 200 day moving average of $44.79, changing hands as low as $43.26 per share. Qiagen NV shares are currently trading off about 3% on the day. The chart below sh... Full story